Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pollen and eosinophilic esophagitis

Matthew I Fogg, Eduardo Ruchelli, Jonathan M Spergel

    The Journal of Allergy and Clinical Immunology
    |October 18, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Allergy is more than type 2 disease.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
    Same author

    Authors' response.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
    Same author

    Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

    The lancet. Gastroenterology & hepatology·2026
    Same author

    Safety and efficacy of three office-based egg oral immunotherapy protocols.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
    Same author

    Vaccine ethics: Balancing individual liberty with protecting the vulnerable.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
    Same author

    Dupilumab improves symptoms and quality of life in patients with eosinophilic esophagitis: a plain language summary.

    Immunotherapy·2026